Jason Madore

9.1k total citations
32 papers, 2.5k citations indexed

About

Jason Madore is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jason Madore has authored 32 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 15 papers in Immunology and 11 papers in Molecular Biology. Recurrent topics in Jason Madore's work include Cancer Immunotherapy and Biomarkers (14 papers), Immunotherapy and Immune Responses (10 papers) and CAR-T cell therapy research (6 papers). Jason Madore is often cited by papers focused on Cancer Immunotherapy and Biomarkers (14 papers), Immunotherapy and Immune Responses (10 papers) and CAR-T cell therapy research (6 papers). Jason Madore collaborates with scholars based in Australia, Canada and United States. Jason Madore's co-authors include Richard A. Scolyer, Georgina V. Long, James S. Wilmott, John F. Thompson, Alexander M. Menzies, Ricardo E. Vilain, Anne‐Marie Mes‐Masson, Peter Hersey, Mark J. Smyth and Jennifer H. Yearley and has published in prestigious journals such as The EMBO Journal, PLoS ONE and Cancer.

In The Last Decade

Jason Madore

32 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason Madore Australia 25 1.6k 1.0k 756 459 320 32 2.5k
Marco de Bruyn Netherlands 30 1.7k 1.0× 1.7k 1.7× 986 1.3× 347 0.8× 440 1.4× 77 3.3k
Fiona Thistlethwaite United Kingdom 21 1.9k 1.1× 567 0.6× 1.2k 1.6× 631 1.4× 422 1.3× 93 2.9k
Hiroko Asanuma Japan 32 1.4k 0.8× 782 0.8× 1.2k 1.6× 520 1.1× 406 1.3× 63 2.6k
Maarten Slagter Netherlands 7 1.4k 0.9× 937 0.9× 598 0.8× 411 0.9× 373 1.2× 9 2.0k
Dario Sangiolo Italy 25 1.4k 0.8× 1.1k 1.1× 549 0.7× 442 1.0× 200 0.6× 76 2.2k
Heidrun Gevensleben Germany 27 904 0.6× 458 0.4× 954 1.3× 639 1.4× 537 1.7× 56 2.1k
Shijun Kang China 12 2.0k 1.2× 1.2k 1.1× 881 1.2× 853 1.9× 552 1.7× 22 3.0k
Cristina Cruz Spain 15 2.8k 1.7× 1.2k 1.2× 922 1.2× 657 1.4× 485 1.5× 36 3.7k
Tarek Meniawy Australia 26 1.2k 0.7× 455 0.4× 639 0.8× 569 1.2× 626 2.0× 95 2.1k
Stefanie Avril United States 22 801 0.5× 415 0.4× 649 0.9× 189 0.4× 418 1.3× 45 1.7k

Countries citing papers authored by Jason Madore

Since Specialization
Citations

This map shows the geographic impact of Jason Madore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Madore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Madore more than expected).

Fields of papers citing papers by Jason Madore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Madore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Madore. The network helps show where Jason Madore may publish in the future.

Co-authorship network of co-authors of Jason Madore

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Madore. A scholar is included among the top collaborators of Jason Madore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Madore. Jason Madore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Casey, Mika, Soi Cheng Law, Muhammed B. Sabdia, et al.. (2022). Inhibition of CD39 unleashes macrophage antibody-dependent cellular phagocytosis against B-cell lymphoma. Leukemia. 37(2). 379–387. 16 indexed citations
2.
Martin, Andrew, J. Guy Lyons, Richard A. Scolyer, et al.. (2020). Nicotinamide for skin cancer chemoprevention: effects of nicotinamide on melanoma in vitro and in vivo. Photochemical & Photobiological Sciences. 19(2). 171–179. 24 indexed citations
3.
Mittal, Deepak, Ailin Lepletier, Jason Madore, et al.. (2019). CD96 Is an Immune Checkpoint That Regulates CD8+ T-cell Antitumor Function. Cancer Immunology Research. 7(4). 559–571. 90 indexed citations
4.
O’Donnell, Jake S., Jason Madore, Xian-Yang Li, & Mark J. Smyth. (2019). Tumor intrinsic and extrinsic immune functions of CD155. Seminars in Cancer Biology. 65. 189–196. 102 indexed citations
5.
Edwards, Jarem, James S. Wilmott, Jason Madore, et al.. (2018). CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment. Clinical Cancer Research. 24(13). 3036–3045. 317 indexed citations
6.
Gide, Tuba N., Alexander M. Menzies, Peter M. Ferguson, et al.. (2018). Inter‐ and intrapatient heterogeneity of indoleamine 2,3‐dioxygenase expression in primary and metastatic melanoma cells and the tumour microenvironment. Histopathology. 74(6). 817–828. 14 indexed citations
7.
Young, Arabella, Shin Foong Ngiow, Jason Madore, et al.. (2017). Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis. Cancer Research. 77(17). 4684–4696. 76 indexed citations
8.
Vilain, Ricardo E., Alexander M. Menzies, James S. Wilmott, et al.. (2017). Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma. Clinical Cancer Research. 23(17). 5024–5033. 191 indexed citations
9.
Kao, Steven, Yuen Yee Cheng, Marissa Williams, et al.. (2017). Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 12(9). 1421–1433. 119 indexed citations
10.
Gallagher, Stuart, Dilini Gunatilake, Kimberley A. Beaumont, et al.. (2017). HDAC inhibitors restore BRAF‐inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma. International Journal of Cancer. 142(9). 1926–1937. 41 indexed citations
11.
Madore, Jason, Dario Strbenac, Ricardo E. Vilain, et al.. (2016). PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma. Clinical Cancer Research. 22(15). 3915–3923. 92 indexed citations
12.
Satgunaseelan, Laveniya, Ruta Gupta, Jason Madore, et al.. (2016). Programmed cell death-ligand 1 expression in oral squamous cell carcinoma is associated with an inflammatory phenotype. Pathology. 48(6). 574–580. 64 indexed citations
13.
Wang, Shu, James S. Wilmott, Jason Madore, et al.. (2015). Detailed Pathological Examination of Completion Node Dissection Specimens and Outcome in Melanoma Patients with Minimal (<0.1 mm) Sentinel Lymph Node Metastases. Annals of Surgical Oncology. 22(9). 2972–2977. 9 indexed citations
14.
Madore, Jason, Ricardo E. Vilain, Alexander M. Menzies, et al.. (2014). PD ‐L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti‐ PD ‐1/ PD ‐ L 1 clinical trials. Pigment Cell & Melanoma Research. 28(3). 245–253. 333 indexed citations
15.
Al‐Ejeh, Fares, Peter T. Simpson, Kerenaftali Klein, et al.. (2014). Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer. Oncogenesis. 3(4). e100–e100. 80 indexed citations
16.
Bell, Emily, Charles Vincent Rajadurai, Sean Cory, et al.. (2012). Crk adaptor proteins act as key signaling integrators for breast tumorigenesis. Breast Cancer Research. 14(3). R74–R74. 50 indexed citations
17.
Oros, Kathleen Klein, Michael C. Quinn, Suzanna L. Arcand, et al.. (2012). The Genomic Landscape of TP53 and p53 Annotated High Grade Ovarian Serous Carcinomas from a Defined Founder Population Associated with Patient Outcome. PLoS ONE. 7(9). e45484–e45484. 33 indexed citations
18.
Ouellet, Véronique, Cécile Le Page, Jason Madore, et al.. (2007). An apoptotic molecular network identified by microarray: On the TRAIL to new insights in epithelial ovarian cancer. Cancer. 110(2). 297–308. 18 indexed citations
19.
Page, Cécile Le, Véronique Ouellet, Jason Madore, et al.. (2006). Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer. British Journal of Cancer. 94(3). 436–445. 39 indexed citations
20.
Page, Cécile Le, Véronique Ouellet, Jason Madore, et al.. (2005). From gene profiling to diagnostic markers: IL‐18 and FGF‐2 complement CA125 as serum‐based markers in epithelial ovarian cancer. International Journal of Cancer. 118(7). 1750–1758. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marco de Bruyn Breakdown of academic impact, for papers by Fiona Thistlethwaite Breakdown of academic impact, for papers by Hiroko Asanuma Breakdown of academic impact, for papers by Maarten Slagter Breakdown of academic impact, for papers by Dario Sangiolo Breakdown of academic impact, for papers by Heidrun Gevensleben Breakdown of academic impact, for papers by Shijun Kang Breakdown of academic impact, for papers by Cristina Cruz Breakdown of academic impact, for papers by Tarek Meniawy Breakdown of academic impact, for papers by Stefanie Avril
Rankless by CCL
2026